An open, randomised, parallel-group phase III study to compare ZOLADEX 3.6 mg monotherapy with ZOLADEX 3.6 mg + tamoxifen or tamoxifen monotherapy in premenopausal Japanese women with oestrogen-positive breast cancer who had undergone curative resection
Study identifier:ZXBC-1002
ClinicalTrials.gov identifier:N/A
EudraCT identifier:N/A
CTIS identifier:N/A
Study Complete
Official Title
An open, randomised, parallel-group phase III study to compare ZOLADEX 3.6 mg monotherapy with ZOLADEX 3.6 mg + tamoxifen or tamoxifen monotherapy in premenopausal Japanese women with oestrogen-positive breast cancer who had undergone curative resection
Medical condition
Breast Cancer
Phase
N/A
Healthy volunteers
-
Study drug
-
Sex
-
Actual Enrollment
-
Study type
Interventional
Age
-
Date
Study Start Date: 01 Jan 1971
Primary Completion Date: -
Study Completion Date: -
Study design
Allocation: -
Endpoint Classification: -
Intervention Model: -
Masking: -
Primary Purpose: -
Verification:
-
Sponsors
AstraZeneca
Collaborators
-
Inclusion and exclusion criteria
Loading...
No locations available
| Arms | Assigned Interventions |
|---|
